ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $140,000 | -58.1% | 116,685 | -54.2% | 0.01% | -50.0% |
| Q1 2022 | $334,000 | +16.8% | 254,665 | +56.8% | 0.02% | -38.9% |
| Q4 2021 | $286,000 | -43.0% | 162,445 | -29.8% | 0.04% | -46.3% |
| Q3 2021 | $502,000 | +74.3% | 231,490 | +181.8% | 0.07% | -30.9% |
| Q2 2021 | $288,000 | -59.5% | 82,145 | +13.9% | 0.10% | -57.3% |
| Q1 2021 | $711,000 | -48.6% | 72,095 | -43.5% | 0.23% | -42.5% |
| Q4 2020 | $1,384,000 | +47.9% | 127,660 | +40.5% | 0.40% | +33.0% |
| Q3 2020 | $936,000 | +49.8% | 90,870 | +203.6% | 0.30% | +40.1% |
| Q2 2020 | $625,000 | +114.0% | 29,930 | 0.0% | 0.21% | +72.4% |
| Q1 2020 | $292,000 | -3.3% | 29,930 | +18.0% | 0.12% | +9.8% |
| Q2 2019 | $302,000 | +2.0% | 25,360 | -73.1% | 0.11% | +34.9% |
| Q4 2018 | $296,000 | -38.5% | 94,113 | +18.4% | 0.08% | -20.2% |
| Q3 2018 | $481,000 | +10.3% | 79,460 | -3.5% | 0.10% | +14.3% |
| Q2 2018 | $436,000 | +3.1% | 82,310 | +12.8% | 0.09% | +11.0% |
| Q1 2018 | $423,000 | – | 72,980 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |